Annexin 1: Differential expression in tumor and mast cells in human larynx cancer

Annexin 1 protein (ANXA1) expression was evaluated in tumor and mast cells in human larynx cancer and control epithelium. The effect of the exogenous ANXA1 (peptide Ac 2‐26) was also examined during the cellular growth of the Hep‐2 human larynx epidermoid carcinoma cell line. This peptide inhibited the proliferation of the Hep‐2 cells within 144 hr. In surgical tissue specimens from 20 patients with larynx cancer, ultrastructural immunocytochemistry analysis showed in vivo down‐regulation of ANXA1 expression in the tumor and increased in mast cells and Hep‐2 cells treated with peptide Ac2‐26. Combined in vivo and in vitro analysis demonstrated that ANXA1 plays a regulatory role in laryngeal cancer cell growth. We believe that a better understanding of the regulatory mechanisms of ANXA1 in tumor and mast cells may lead to future biological targets for the therapeutic intervention of human larynx cancer. © 2007 Wiley‐Liss, Inc.

[1]  P R Taylor,et al.  Loss of annexin 1 correlates with early onset of tumorigenesis in esophageal and prostate carcinoma. , 2000, Cancer research.

[2]  R. Gillet,et al.  Annexin 1 expression and phosphorylation are upregulated during liver regeneration and transformation in antithrombin iii sv40 t large antigen transgenic mice , 2000, Hepatology.

[3]  I. Rahman,et al.  Annexin A1 processing is associated with caspase‐dependent apoptosis in BZR cells , 2003, FEBS letters.

[4]  Y. Furuta,et al.  Localization of annexin I (lipocortin I, p35) mRNA in normal and diseased human skin by in situ hybridization , 1996, Archives of Dermatological Research.

[5]  M. Perretti,et al.  Transfection of annexin 1 in monocytic cells produces a high degree of spontaneous and stimulated apoptosis associated with caspase‐3 activation , 2001, British journal of pharmacology.

[6]  S. Moss,et al.  Annexins and disease. , 2004, Biochemical and biophysical research communications.

[7]  J. Rodrigo,et al.  Annexin A1 down-regulation in head and neck cancer is associated with epithelial differentiation status. , 2004, The American journal of pathology.

[8]  C. Bryant,et al.  Annexin 1 regulates cell proliferation by disruption of cell morphology and inhibition of cyclin D1 expression through sustained activation of the ERK1/2 MAPK signal. , 2003, Experimental cell research.

[9]  G. Nilsson,et al.  Mast cell infiltration correlates with poor prognosis in Hodgkin's lymphoma , 2002, British journal of haematology.

[10]  R. Flower,et al.  Lipocortin 1 mediates dexamethasone-induced growth arrest of the A549 lung adenocarcinoma cell line. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[11]  J. Ferlay,et al.  Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.

[12]  M. Perretti,et al.  Modulation of IL-1-induced neutrophil migration by dexamethasone and lipocortin 1. , 1993, Journal of immunology.

[13]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[14]  M. Perretti,et al.  Time-dependent expression of annexin 1 in a model of chronic granulomatous inflammation , 2002, Inflammation Research.

[15]  R. Flower,et al.  Lipocortin-1: cellular mechanisms and clinical relevance. , 1994, Trends in pharmacological sciences.

[16]  J. Rak,et al.  Host microenvironment in breast cancer development: Inflammatory and immune cells in tumour angiogenesis and arteriogenesis , 2003, Breast Cancer Research.

[17]  E. Vokes,et al.  Therapeutic options for laryngeal cancer. , 2003, The New England journal of medicine.

[18]  S. Jimi,et al.  Cutaneous malignant melanoma: correlation between neovascularization and peritumor accumulation of mast cells overexpressing vascular endothelial growth factor. , 2000, Human pathology.

[19]  G. Stassi,et al.  Induction of annexin-1 during TRAIL-induced apoptosis in thyroid carcinoma cells , 2005, Cell Death and Differentiation.

[20]  M. Perretti,et al.  Increased apoptosis in U937 cells over-expressing lipocortin 1 (annexin I). , 2000, Life sciences.

[21]  S. Nelson,et al.  Loss of annexin A1 expression in human breast cancer detected by multiple high-throughput analyses. , 2004, Biochemical and biophysical research communications.

[22]  G. Griffiths,et al.  Localization of five annexins in J774 macrophages and on isolated phagosomes. , 1997, Journal of cell science.

[23]  S. Marullo,et al.  A novel calcium‐dependent proapoptotic effect of annexin 1 on human neutrophils , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[24]  R. Strausberg,et al.  Identifying potential tumor markers and antigens by database mining and rapid expression screening. , 2000, Genome research.

[25]  S. Erkılıç,et al.  Can smoking and/or occupational UV exposure have any role in the development of the morpheaform basal cell carcinoma? A critical role for peritumoral mast cells , 2002, International journal of dermatology.

[26]  H. Aburatani,et al.  Differential gene expression profiles of scirrhous gastric cancer cells with high metastatic potential to peritoneum or lymph nodes. , 2001, Cancer research.

[27]  G. Casey,et al.  Identification of metastasis-associated proteins through protein analysis of metastatic MDA-MB-435 and metastasis-suppressed BRMS1 transfected-MDA-MB-435 cells , 2004, Clinical & Experimental Metastasis.

[28]  H. Christian,et al.  An Immunocytochemical and In Situ Hybridization Analysis of Annexin 1 Expression in Rat Mast Cells: Modulation by Inflammation and Dexamethasone , 2000, Laboratory Investigation.

[29]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[30]  M. Perretti,et al.  A Novel Effect for Annexin 1-Derived Peptide Ac2-26: Reduction of Allergic Inflammation in the Rat , 2005, Journal of Pharmacology and Experimental Therapeutics.

[31]  M. Perretti,et al.  Annexin I Regulates SKCO-15 Cell Invasion by Signaling through Formyl Peptide Receptors* , 2006, Journal of Biological Chemistry.

[32]  Sei-Hyun Ahn,et al.  Differential expression of annexin I in human mammary ductal epithelial cells in normal and benign and malignant breast tissues , 1997, Clinical & Experimental Metastasis.

[33]  Wei Xin,et al.  Dysregulation of the annexin family protein family is associated with prostate cancer progression. , 2003, The American journal of pathology.

[34]  E. Tajara,et al.  In vitro and in vivo studies on CCR10 regulation by Annexin A1 , 2006, FEBS letters.

[35]  F. Speleman,et al.  Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes , 2002, Genome Biology.

[36]  O. Al‐Shabanah,et al.  Protective effect of aminoguanidine, a nitric oxide synthase inhibitor, against carbon tetrachloride induced hepatotoxicity in mice. , 1999, Life sciences.

[37]  P. Conti,et al.  Mast cells: the Jekyll and Hyde of tumor growth. , 2004, Trends in immunology.

[38]  P. Xie,et al.  Significance and relationship between infiltrating inflammatory cell and tumor angiogenesis in hepatocellular carcinoma tissues. , 2005, World journal of gastroenterology.

[39]  S. Violette,et al.  Role of lipocortin I in the glucocorticoid induction of the terminal differentiation of a human squamous carcinoma , 1990, Journal of cellular physiology.

[40]  S M Hanash,et al.  An immune response manifested by the common occurrence of annexins I and II autoantibodies and high circulating levels of IL-6 in lung cancer , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[41]  S. Takai,et al.  Expression of chymase‐positive cells in gastric cancer and its correlation with the angiogenesis , 2006, Journal of surgical oncology.